These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8533130)

  • 1. Renal blood flow, fibrinolysis, and platelet aggregation following tacrolimus (FK 506) treatment in rats.
    Mugiya S; Suzuki K; Ueda D; Ohtawara Y; Fujita K; Malyszko J; Urano T; Knofler R; Takada Y; Takada A
    Thromb Res; 1995 Aug; 79(3):337-41. PubMed ID: 8533130
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal blood flow and serotonin metabolism in tacrolimus treated rats.
    Mugiya S; Fujita K; Malyszko J; Takada Y; Takada A
    Int J Urol; 1996 May; 3(3):187-90. PubMed ID: 8776615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
    Pelekanou V; Trezise AE; Moore AL; Kay JE
    Transplant Proc; 1991 Dec; 23(6):3200-1. PubMed ID: 1721408
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of mycophenolic acid and FK-506 on human platelet activation in vitro.
    Klein BC; Bach D; Rehfeld I; Kirchhoff E; Hohlfeld T; Schrör K; Scharf R; Grabensee B
    Kidney Blood Press Res; 2000; 23(2):119-24. PubMed ID: 10765114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK 506 affects platelet aggregation in vitro.
    Malyszko J; Takada Y; Urano T; Takada A
    Thromb Res; 1994 Jul; 75(1):99-104. PubMed ID: 7521072
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of human platelet aggregation and secretion induced by rapamycin.
    Babinska A; Markell MS; Salifu MO; Akoad M; Ehrlich YH; Kornecki E
    Nephrol Dial Transplant; 1998 Dec; 13(12):3153-9. PubMed ID: 9870481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation.
    Suehiro A; Sawada A; Hasegawa Y; Takatsuka H; Higasa S; Kakishita E
    Bone Marrow Transplant; 2002 Jan; 29(2):107-11. PubMed ID: 11850703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 does not affect the glomerular filtration rate and renal plasma flow in the rat.
    Perico N; Amuchastegui CS; Zoja C; Benigni A; Morigi M; Remuzzi G
    Transplant Proc; 1991 Dec; 23(6):3123-5. PubMed ID: 1721378
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood.
    Muraki T; Taka T; Noguchi T; Ishii H; Seki J; Yamamoto J
    Transplantation; 1998 Apr; 65(8):1132-4. PubMed ID: 9583878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphinpyrazone inhibits platelet function and enhances blood fibrinolytic activity in the rat.
    Hussaini IM; Moore PK
    Thromb Res; 1988 Nov; 52(4):337-41. PubMed ID: 3201405
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive effect of FK 506 (tacrolimus hydrate) on experimentally induced acute liver injury in rats.
    Uchida K; Sakaida I; Hironaka K; Kayano K; Okita K
    Dig Dis Sci; 2000 Oct; 45(10):1996-2001. PubMed ID: 11117573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunosuppressive agents (FK-506, rapamycin) on renal P450 systems in rat models.
    Yoshimura R; Yoshimura N; Ohyama A; Ohmachi T; Yamamoto K; Kishimoto T; Wada S
    J Pharm Pharmacol; 1999 Aug; 51(8):941-8. PubMed ID: 10504034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of finoptin on platelet aggregation, blood coagulability and fibrinolysis in patients with ischemic heart disease during physical exercise].
    Kovalenko VM; Shunkova EI; Gol'dberg GA; Karagaeva LG; Shlafer ID; Epifantseva NN
    Kardiologiia; 1991 Sep; 31(9):42-4. PubMed ID: 1753613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
    Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
    Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981).
    Fox SC; Judge HM; Allen BR; Heptinstall S
    Platelets; 2002 Jun; 13(4):213-8. PubMed ID: 12189022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats.
    McLaughlin GE; Kashimawo LA; Steele BW; Kuluz JW
    Pediatr Crit Care Med; 2003 Jul; 4(3):358-62. PubMed ID: 12831420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tacrolimus on hemodynamics and absorption of experimental small intestinal transplants.
    Sun S; Katz SM; Schechner RS; Tellis VA; Greenstein SM
    Transplantation; 1996 May; 61(10):1447-50. PubMed ID: 8633368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver.
    Weinbroum AA; Isartal I; Almogy N; Nakache R
    Transplant Proc; 2001 Sep; 33(6):2962-3. PubMed ID: 11543812
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients.
    Sahin G; Akay OM; Bal C; Yalcin AU; Gulbas Z
    Clin Nephrol; 2011 Sep; 76(3):218-25. PubMed ID: 21888859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of FK 506 on renal blood flow.
    Ueda D; Tajima A; Ohtawara Y; Ishikawa A; Nakano M; Ushiyama T; Ohta N; Kawabe K; Aso Y
    Transplant Proc; 1991 Dec; 23(6):3121-2. PubMed ID: 1721377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.